Theme logo
Ask Lilly

Ask Lilly your questions!
We’re here to help.

Call:
1-844-OLUMIANT
(1-844-658-6426)
Olumiant Together logo

Supporting You Every Step of The Way

Olumiant Together is a support program that gives you access to the Companion in Care™ team. A Companion in Care is available to answer questions, assist with confirming your insurance coverage, and provide guidance throughout your treatment.

He or she can provide support, help you prepare for a discussion with your doctor, or simply lend an ear whenever you want to talk.

You can enroll in Olumiant Together and if eligible get your Olumiant Savings Card* today in a few short steps.

Enroll now

If you are not eligible for a savings card, you can still enroll in Olumiant Together by calling 1-844-OLUMIANT (1-844-658-6426)

To get your savings card*, we need your HIPAA authorization to work on your behalf to ensure you’re at the right specialty pharmacy and paying as little as $5 or $25 a month.

As a reminder, HIPAA is the Health Insurance Portability and Accountability Act that provides data privacy and security to protect your medical information.

*Offer good until 12/31/2020. $5 monthly offer subject to wholesale acquisition cost plus usual and customary pharmacy charges and a separate maximum annual cap of $12,000. $25 monthly offer subject to monthly and annual cap of wholesale acquisition cost plus usual and customary pharmacy charges. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims are eligible to be reimbursed, in whole or in part, by Medicare Part D, Medicaid, TRICARE or any other state or federal program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation is required. Subject to additional terms and conditions, which can be found here.

Help throughout your treatment journey

Start strong

Start strong

The Companion in Care team can answer frequently asked questions about Olumiant, RA, your insurance coverage, and the Olumiant savings program*.

Keep going

Keep going

Olumiant Together can help you prepare for productive discussions with your doctor and provide resources and information about living with RA.

Reach out

Reach out

We're here to lend an ear whenever you want to talk. Please keep in mind that a Companion in Care is not a substitute for your healthcare provider and cannot provide medical or treatment advice.

How can I enroll?

You can enroll in Olumiant Together and, if you have commercial insurance, can request your Olumiant Savings Card in 3 ways:

Phone number to enroll for Olumiant Together

Once I enroll, what’s next?

Step 1

Email and text welcoming you to Olumiant Together

You’ll first receive an email and text welcoming you to Olumiant Together. Our Companion in Care team will contact you soon.

Step 2

Welcome call from Companion in Care support

A Companion in Care will give you a welcome call to talk about how Olumiant Together can support you throughout your treatment journey and provide an update on your insurance coverage before you begin treatment.

Step 3

Welcome package from Companion in Care support

You’ll get a welcome package in the mail from us.

Step 4

clipboard

After that, you’re all set. Your Olumiant will be scheduled for delivery. Feel free to reach out to a Companion in Care for ongoing support.

Step 5

phone

We’ll give you a call to be sure you received your first shipment of Olumiant and answer any questions you may have.

The Companion in Care team will continue to check in on how you are feeling and follow your progress. You can connect with a member of the Companion in Care team any time you have a question or just want to talk by calling 1-844-OLUMIANT (1-844-658-6426) Monday-Friday between 8 AM and 10 PM ET.

INDICATION AND IMPORTANT SAFETY INFORMATION Warning: Serious Infections, Cancers and Blood Clots
Warning: Serious Infections, Cancers and Blood Clots
INDICATION

Olumiant is an oral prescription medicine called a Janus kinase (JAK) inhibitor used to treat adults with moderate to severe rheumatoid arthritis (RA) who have not responded well enough to or could not tolerate at least one medicine called a tumor necrosis factor (TNF) antagonist. It is not known if Olumiant is safe and effective in children.

IMPORTANT SAFETY INFORMATION
THE MOST IMPORTANT INFORMATION YOU SHOULD KNOW ABOUT OLUMIANT:

  • Serious infections. Olumiant is a medicine that affects your immune system. Olumiant can lower your immune system’s ability to fight infections, which can make you more likely to get infections or make infections worse. Some people have had serious infections while using Olumiant, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your healthcare provider (HCP) should test you for TB before starting Olumiant and watch closely for signs and symptoms of TB during treatment. You should not start Olumiant if you have any kind of infection unless your HCP tells you it is okay. You may be at higher risk of developing shingles. While taking Olumiant, tell your HCP right away if you have symptoms of an infection, including:

    • fever
    • sweating
    • chills
    • muscle aches
    • cough
    • shortness of breath
    • blood in phlegm
    • weight loss
    • warm, red, or painful skin or sores
    • diarrhea or stomach pain
    • burning with urination or urinating more often than normal
    • feeling very tired
  • Cancer and immune system problems. Olumiant may increase your risk of certain cancers by changing the way your immune system works. Lymphoma and other cancers including skin cancers, can happen in people taking Olumiant.
  • Blood clots in the veins of your legs (deep vein thrombosis, DVT) or lungs (pulmonary embolism, PE) can happen in some people taking Olumiant. This may be life-threatening and cause death. While taking Olumiant, tell your HCP right away if you have any signs and symptoms of blood clots, including swelling, pain or tenderness in the leg, sudden unexplained chest pain, or shortness of breath.
  • Tears in the stomach or intestines can happen to some people taking Olumiant. This happens most often in people who also take nonsteroidal anti-inflammatory drugs, corticosteroids, or methotrexate. While taking Olumiant, tell your HCP right away if you have fever and stomach-area pain that does not go away, and a change in your bowel habits.
  • Changes in laboratory test results. Your HCP should routinely check certain liver tests and should do blood tests before you start and while you take Olumiant to check your lymphocyte (white blood cells), neutrophil (white blood cells), and red blood cell counts. You should not take Olumiant if your blood cell counts are too low or your liver blood tests are too high. Your HCP may stop Olumiant for a period of time if these test results change. Your HCP should check your cholesterol levels approximately 12 weeks after you start Olumiant and as needed after that, as blood cholesterol levels may change.
BEFORE STARTING OLUMIANT

BEFORE STARTING OLUMIANT, TELL YOUR HCP ABOUT ALL YOUR MEDICAL CONDITIONS, INCLUDING IF YOU:

  • are being treated for an infection, have an infection that won’t go away or keeps coming back, or think you have symptoms of an infection
  • have TB or have been in close contact with someone with TB
  • have had hepatitis B or C
  • live or have lived, or have traveled to certain parts of the country (such as the Ohio and Mississippi River Valleys and the Southwest) with an increased chance for getting certain fungal infections. These infections may happen or become more severe if you use Olumiant.
  • have diabetes, chronic lung disease, HIV, or a weak immune system. People with these conditions have a higher chance for infections while taking Olumiant.
  • have ever had any type of cancer
  • have had blood clots in the veins of your legs or lungs in the past
  • have any stomach-area pain or have been diagnosed with diverticulitis (inflammation in the large intestine) or ulcers in your stomach or intestines
  • have kidney problems, liver problems, or low red or white blood cell counts
  • have recently received or are scheduled to receive a vaccine. People who take Olumiant should not receive live vaccines.
  • are pregnant or plan to become pregnant. It is not known if Olumiant will harm an unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if Olumiant passes into your breast milk. You and your healthcare provider should decide if you will take Olumiant or breastfeed. You should not do both.
TALK TO YOUR DOCTOR

Also tell your HCP about all medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Especially tell your HCP if you take a medicine called probenecid or any medicine to treat rheumatoid arthritis, such as tocilizumab (Actemra®), etanercept (Enbrel®), adalimumab (Humira®), infliximab (Remicade®), rituximab (Rituxan®), abatacept (Orencia®), anakinra (Kineret®), certolizumab pegol (Cimzia®), golimumab (Simponi®), tofacitinib (Xeljanz®; Xeljanz XR®), sarilumab (Kevzara®), azathioprine, or cyclosporine. Taking Olumiant with these medicines may increase your risk of infection.

COMMON SIDE EFFECTS

The most common side effects of Olumiant include upper respiratory tract infections (common cold, sinus infections), nausea, cold sores, and shingles. Tell your HCP about any side effect that bothers you or that does not go away.

These are not all of the possible side effects of Olumiant. Ask your doctor for medical advice about side effects. You are encouraged to report side effects to the FDA at 1-800-FDA-1088 or visit www.fda.gov/medwatch.

ADDITIONAL INFORMATION

Olumiant is available by prescription only.

Please see full Prescribing Information, including Boxed Warning on Serious Infections, Cancers, and Blood Clots, and Medication Guide.

BA CON ISI 01JUN2018

All trademarks are property of their respective owners.

Are you a US healthcare provider?

The information contained in this section of olumiant.com is intended for US healthcare providers. Please confirm below.

You are now leaving olumiant.com.

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click “Continue” to leave site or “Return to olumiant.com” to close this window and return to olumiant.com.

Terms and Conditions:

$5 monthly offer subject to wholesale acquisition cost plus usual and customary pharmacy charges and a separate maximum annual cap of $12,000. $25 monthly offer subject to a monthly and annual cap of wholesale acquisition cost plus usual and customary pharmacy charges. If you meet program eligibility requirements, have commercial insurance, and your insurance provider covers Olumiant, you are eligible to pay $5 monthly. If you meet program eligibility requirements, have commercial insurance, and your insurance provider denies coverage and a PA, and then an appeal is submitted for Olumiant, you are eligible to pay $25 monthly. To continue to participate in the $25 monthly program, patients who qualify are required to submit and have an appeal decision within 6 months post program initiation, to verify coverage status and potential eligibility for the $5 monthly program. Eligible patients may be able to use the $5 and $25 monthly offers until 12/31/2020 provided they continue to meet program criteria.

*By using the Olumiant Savings Card (“Card”), you attest that you meet the eligibility criteria and will comply with the Terms and Conditions described below:

Offer void where prohibited by law. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims are eligible to be reimbursed, in whole or in part, by any governmental program, including, without limitation, Medicaid, Medicare, Medicare Part D, Medigap, DOD, VA, TRICARE/CHAMPUS, or any state patient or pharmaceutical assistance program. If you live in Massachusetts, the Card expires on the earlier of: (i) the expiration date of this Card (12/31/2020); (ii) the date an AB-rated generic equivalent for Olumiant becomes available; or (iii) June 30, 2019, absent a change in Massachusetts state law. If you live in California, the Card expires on the earlier of: (i) the expiration date of this Card (12/31/2020) or (ii) the date an FDA-approved therapeutically equivalent for Olumiant or over-the-counter product with the same active ingredients becomes available. Available only in the US and Puerto Rico for residents of the US and Puerto Rico. By accepting this offer, you agree that if you are required to do so under the terms of your insurance coverage for this prescription or are otherwise required to do so by law, you should notify your insurance carrier of your redemption of this Card. This offer is not valid with any other program, discount, incentive, or similar offer involving Olumiant. It is prohibited for any person to sell, purchase, or trade; or to offer to sell, purchase, or trade; or to counterfeit this Card. This offer may be terminated, rescinded, revoked, or amended by Lilly USA, LLC, at any time without notice. This Card is not health insurance. This Card expires on 12/31/2020.